Merck & Co's chief medical officer and head of clinical development Dr Roy Baynes has announced his retirement from the company to take up a new role alongside his former colleague Roge
Voyager Therapeutics has lost little time in elevating Al Sandrock to the chief executive position, with the appointment coming just a few weeks after he joined the biotech's board.
Gaming industry veteran Jon David, responsible for highly-downloaded mobile games, including the Bejeweled and Plants vs Zombies franchises, has moved into the digital health arena by takin
Hundreds of business leaders in the life sciences sector have added their names to an open letter that says they will cease all business dealings in Russia in response to Russia's unprovoke
It's official – President Joe Biden's choice for FDA commissioner, Robert Califf, has been confirmed to the role after a narrow 50 to 46 vote in the Senate that relied on crossover Republic
Al Sandrock's shock departure from Biogen in November sparked speculation about where he would show up next, and the answer came in today – gene therapy specialist Voyager Therapeutics.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.